DVS® is the first permanently implantable, wireless, telemetric, radiation sensor for human use to be commercially available in the United States. The FDA has cleared its use in both prostate and breast cancer patients.
Over time this important new technology may demonstrate its value by helping physicians confirm that the prescribed dose of radiation has been accurately delivered. Using proprietary telemetric technology, Sicel's miniature DVS® sensor (20mm x 2mm) provides the unique capability to measure the amount of radiation received by the tumor.
Department of Radiation Oncology
The Brody School of Medicine at East Carolina University
600 Moye Blvd.
Greenville, NC 27834
Phone (252) 744-2900 / Fax (252) 744-2812
